Telomir Pharmaceuticals, INC. 8-K Filing
Ticker: TELO · Form: 8-K · Filed: Nov 20, 2025 · CIK: 1971532
Sentiment: neutral
Filing Stats: 847 words · 3 min read · ~3 pages · Grade level 17.4 · Accepted 2025-11-20 16:01:58
Filing Documents
- form8-k.htm (8-K) — 44KB
- 0001493152-25-024450.txt ( ) — 211KB
- telo-20251120.xsd (EX-101.SCH) — 3KB
- telo-20251120_lab.xml (EX-101.LAB) — 33KB
- telo-20251120_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TELOMIR PHARMACEUTICALS, INC. Dated: November 20, 2025 By: /s/ Erez Aminov Name: Erez Aminov Title: Chief Executive Officer